Alnylam Pharmaceuticals, Inc ALNY
NASDAQ · United States · Health Technology
$236.38-10.36 (-4.20%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $249.90 | -5.41% · below |
| 50-period average | $242.57 | -2.55% · below |
| 200-period average | $303.76 | -22.18% · below |
| Avg. volume (1Y) | 1.40M |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.